Сравнение методов

	Опросник по воспалительным заболеваниям кишечника	EORTC QLQ-C30
Область	Исходы для здоровья	Исходы для здоровья
Семейство	Process / pipeline	Process / pipeline
Год появления	1994	1993
Автор метода	Elena J. Irvine et al.	Nico Aaronson et al.
Тип	Self-report quality of life questionnaire	Self-report quality of life questionnaire
Основополагающий источник	Guyonnet, S., Dupont, C., Mouterde, O., Chouraqui, J. P., Darmaun, D., & Goulet, O. (2001). Placebo-controlled trial of saccharomyces boulardii in gastroenteritis. Pediatrics, 107(2), E27.	Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376.
Другие названия	IBDQ, IBD Questionnaire, Inflammatory Bowel Disease QoL	QLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
Связанные	4	5
Сводка	The IBDQ is a disease-specific quality of life measure for inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. Developed by Elena Irvine and colleagues in 1994, this 32-item questionnaire measures how IBD affects bowel function, systemic symptoms, emotional well-being, and social functioning. It is the most widely used quality-of-life instrument in IBD research and clinical practice.	The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.